exercise

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…

2 weeks ago

BioVie Inc. Announces Pricing of $12 Million Public Offering

August 07, 2025 20:43 ET  | Source: BioVie, Inc. CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc.…

4 weeks ago

Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM

July 25, 2025 20:00 ET  | Source: Diginex Limited LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…

1 month ago

Soluna Holdings, Inc. Announces Pricing of $5 Million Public Offering

ALBANY, N.Y.--(BUSINESS WIRE)--$SLNH #SLNH--Soluna Holdings, Inc. (“Soluna” or the “Company”) (NASDAQ: SLNH), a developer of green data centers for intensive…

2 months ago

Biomea Fusion Announces Pricing of Public Offering of Securities

June 17, 2025 23:15 ET  | Source: Biomea Fusion, Inc. REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Biomea…

3 months ago

Mogo Applies to Extend the Expiry Dates of Certain Warrants

VANCOUVER, British Columbia--(BUSINESS WIRE)--Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) (“Mogo” or the “Company”), a digital wealth and payments business, today announced that…

3 months ago

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

3 months ago

Fagron increases share capital through exercise subscription rights

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron…

3 months ago

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full…

3 months ago

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

June 06, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 14 / 2025 Zealand Pharma increases its…

3 months ago